Horizon Therapeutics PLC (HZNP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

CONNAUGHT HOUSE, 1ST FLOOR DUBLIN, IRELAND 4

Horizon Pharma, Inc., a biopharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis.

Data as of 2020-07-04
Market Cap10.825 Billion Shares Outstanding195.962 Million Avg 30-day Volume2.782 Million
P/E Ratio18.4 Dividend Yield EPS3
Price/Sales10.261 Price cash flow ratio37.6 Price free cash flow ratio-572.7
Book Value11.17 Price to Tangible Book425.74 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.128371
BETA1.21552 52-week High/Low57.34 / 22.69 Stddev0.144471
View SEC Filings from HZNP instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 17 10 (0.65%)
13F Filers holding this stock: 288 101 (6.61%)
Aggregate 13F shares on 03/31/2020: 171.687 Million 110.883 Million
Aggregate 13F shares on 12/31/2019: 170.551 Million 103.244 Million
Percent change: 0.67% 7.40%
Funds creating new positions: 55 22
Funds Adding to an existing position: 94 29
Funds closing out their position: 39 16
Funds reducing their position: 112 45
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding HZNP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HZNP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

131.2 Thousand total shares from 11 transactions

Exercise Derivative Conversion (M)

93.7 Thousand total shares from 9 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MOZE BARRY EVP, CHIEF ADMIN. OFFICER

  • Officer
178,209 2020-07-07 6

KENT JEFF SEE REMARKS

  • Officer
98,993 2020-07-07 8

SHERMAN JEFFREY W EVP AND CHIEF MEDICAL OFFICER

  • Officer
293,812 2020-07-06 4

BIRD JEFFREY W

  • Director
0 2020-07-02 0

GREY MICHAEL G

  • Director
62,290 2020-06-25 3

FORMELA JEAN FRANCOIS

  • Director
0 2020-06-18 0

WITZ PASCALE

  • Director
0 2020-06-17 2

KELLY DAVID GEORGE

  • Director
37,108 2020-06-13 0

WATKINS THOMAS

  • Director
40,323 2020-06-11 1

MAHONY SUSAN

  • Director
0 2020-06-11 3

MCHUGH MILES W SR VP & PRINC. ACCTG OFFICER

  • Officer
33,721 2020-06-10 9

WALBERT TIMOTHY P

  • Director
0 2020-06-04 7

LIN SHAO-LEE

  • Director
0 2020-06-04 2

SANTINI GINO

  • Director
41,473 2020-06-02 1

BEELER BRIAN K EVP, GENERAL COUNSEL

  • Officer
35,885 2020-06-01 12

KARNANI VIKRAM EVP, CHIEF COMMERCIAL OFFICER

  • Officer
42,169 2020-06-01 6

BOCK LOUIS C

  • Director
0 2020-05-29 0

CURTIS GEOFFREY M. EVP, CORPORATE AFFAIRS, CCO

  • Officer
35,254 2020-05-26 7

SHANNON JAMES SAMUEL

  • Director
0 2020-05-21 3

SMITH TODD N PRESIDENT AND CEO

  • Officer
  • Director
0 2020-05-20 0

CAREY ROBERT

  • Director
15,000 2020-05-18 0

KONSTANTINOVSKY IRINA EVP, CHIEF HUMAN RESOURCES OFF

  • Officer
35,389 2020-05-06 7

HOELSCHER PAUL W. EVP, CFO

  • Officer
132,501 2020-05-05 8

DESJARDIN MICHAEL A. EVP, TECHNICAL OPERATIONS

  • Officer
64,359 2020-05-05 7

HIMAWAN JEFF

  • Director
42,881 2020-04-30 1

DANIEL WILLIAM F

  • Director
66,362 2020-04-30 1

HAMPTON GEORGE P

  • Director
22,146 2020-01-24 0

MOSBROOKER ERIC SVP, CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-01-15 0

VENKATARAMAN BALAJI CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
0 2020-01-03 0

PASTERNAK ANDY EVP AND CHIEF BUSINESS OFFICER

  • Officer
0 2020-01-03 3

NOHRIA VIRINDER

  • 10% Owner
  • SEE EXPLANATION OF RESPONSES
110,000 2019-08-22 0

PAULI RONALD

  • Director
33,600 2019-05-02 0

WALBERT TIMOTHY P CHAIRMAN, PRESIDENT AND CEO

WALBERT TIMOTHY P CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
680,757 2019-01-04 7

ESSEX WOODLANDS HEALTH VENTURES FUND VII LP

  • 10% Owner
No longer subject to file 2018-11-27 0

BIRNER HUBERT

  • Director
  • 10% Owner
0 2018-06-08 0

HAPPEL DAVID EVP, COMMERCIAL DEV & STRATEGY

  • Officer
5,089 2017-10-25 0

ACKERMAN TIMOTHY J. SVP, COMMERCIAL OPERATIONS

  • Officer
41,129 2017-01-10 0

THOMAS JOHN B EVP, CORPORATE STRATEGY AND IR

  • Officer
7,620 2016-05-06 0

KODY JOHN J EVP, CHIEF COMMERCIAL OFFICER

  • Officer
12,766 2015-11-24 0

DE VAERE ROBERT J EVP & CFO

  • Officer
No longer subject to file 2014-09-30 0

VIDARA THERAPEUTICS HOLDINGS LLC

  • 10% Owner
  • FORMER 10% OWNER
No longer subject to file 2014-09-22 0

QUAKER BIOVENTURES II LP

  • 10% Owner
No longer subject to file 2014-02-21 0

ADATTO MICHAEL SVP, MANAGED CARE & COMM. DEV.

  • Officer
22,911 2012-12-31 0

JOHANN PETER

  • Director
No longer subject to file 2012-03-07 0

ATLAS VENTURE FUND VI LP

ATLAS VENTURE FUND VI GMBH & CO KG

ATLAS VENTURE ASSOCIATES VI, L.P.

ATLAS VENTURE ENTREPRENEURS FUND VI LP

  • 10% Owner
No longer subject to file 2012-03-02 0

SCALE VENTURE PARTNERS II, LP

SCALE VENTURE MANAGEMENT II, LLC

MITCHELL KATE

O'DRISCOLL RORY

WIENBAR SHARON L

  • FORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDER
No longer subject to file 2011-09-21 0

ATLAS VENTURE FUND VI LP

ATLAS VENTURE ASSOCIATES VI, INC

ATLAS VENTURE ENTREPRENEURS FUND VI LP

ATLAS VENTURE FUND VI GMBH & CO KG

  • 10% Owner
5,393,178 2011-08-02 0

NGN BIOMED OPPORTUNITY I GMBH & CO. BETEILIGUNGS KG

NGN BIOMED OPPORTUNITY I L P

  • 10% Owner
123,287 2011-07-28 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

KENT JEFF - Officer SEE REMARKS

2020-07-07 M 18,000 $7.61 a 98,993 98,993.00 direct

MOZE BARRY - Officer EVP, CHIEF ADMIN. OFFICER

2020-07-07 M 10,000 d 0 178,209.00 direct

MOZE BARRY - Officer EVP, CHIEF ADMIN. OFFICER

2020-07-07 M 10,000 $8.50 a 178,209 178,209.00 direct

KENT JEFF - Officer SEE REMARKS

2020-07-07 M 18,000 d 0 98,993.00 direct

KENT JEFF - Officer SEE REMARKS

2020-07-07 M 20,000 $3.95 a 80,993 98,993.00 direct

MOZE BARRY - Officer EVP, CHIEF ADMIN. OFFICER

2020-07-07 M 17,257 d 443 178,209.00 direct

MOZE BARRY - Officer EVP, CHIEF ADMIN. OFFICER

2020-07-07 M 17,257 $11.81 a 168,209 178,209.00 direct

KENT JEFF - Officer SEE REMARKS

2020-07-07 M 20,000 d 0 98,993.00 direct

MOZE BARRY - Officer EVP, CHIEF ADMIN. OFFICER

2020-07-07 M 7,819 d 165,181 178,209.00 direct

MOZE BARRY - Officer EVP, CHIEF ADMIN. OFFICER

2020-07-07 M 7,819 $22.14 a 150,952 178,209.00 direct

SHERMAN JEFFREY W - Officer EVP AND CHIEF MEDICAL OFFICER by trust

2020-07-06 S 9,100 $57.50 d 278,797 293,812.00 indirect yes

MOZE BARRY - Officer EVP, CHIEF ADMIN. OFFICER

2020-07-01 S 2,109 $55.48 d 143,133 143,133.00 direct yes

MOZE BARRY - Officer EVP, CHIEF ADMIN. OFFICER

2020-07-01 S 21,049 $54.56 d 145,242 143,133.00 direct yes

GREY MICHAEL G - Director

2020-06-25 S 1,755 $55.00 d 0 62,290.00 direct yes

GREY MICHAEL G - Director

2020-06-25 M 1,755 $3.95 a 1,755 62,290.00 direct

GREY MICHAEL G - Director

2020-06-25 M 1,755 d 3,510 62,290.00 direct

MCHUGH MILES W - Officer SR VP & PRINC. ACCTG OFFICER

2020-06-10 F 1,477 $48.60 d 33,721 33,721.00 direct

KENT JEFF - Officer SEE REMARKS

2020-06-10 S 2,785 $48.05 d 60,993 60,993.00 direct yes

MCHUGH MILES W - Officer SR VP & PRINC. ACCTG OFFICER

2020-06-10 M 3,333 a 35,198 33,721.00 direct

KENT JEFF - Officer SEE REMARKS

2020-06-10 F 2,216 $48.60 d 63,778 60,993.00 direct

MCHUGH MILES W - Officer SR VP & PRINC. ACCTG OFFICER

2020-06-10 M 3,333 d 3,334 33,721.00 direct

KENT JEFF - Officer SEE REMARKS

2020-06-10 M 5,000 d 5,000 60,993.00 direct

KENT JEFF - Officer SEE REMARKS

2020-06-10 M 5,000 a 65,994 60,993.00 direct

KENT JEFF - Officer SEE REMARKS

2020-06-01 S 8,100 $50.59 d 60,994 60,994.00 direct yes

KARNANI VIKRAM - Officer EVP, CHIEF COMMERCIAL OFFICER

2020-06-01 S 2,369 $50.23 d 42,169 42,169.00 direct yes

KENT JEFF - Officer SEE REMARKS

2020-06-01 S 49,115 $49.83 d 69,094 60,994.00 direct yes

BEELER BRIAN K - Officer EVP, GENERAL COUNSEL

2020-06-01 S 2,370 $50.23 d 35,885 35,885.00 direct yes

CURTIS GEOFFREY M. - Officer EVP, CORPORATE AFFAIRS, CCO

2020-05-26 S 21,918 $49.85 d 34,834 35,254.00 direct yes

GREY MICHAEL G - Director

2020-05-22 M 10,530 $7.84 a 10,530 62,290.00 direct

GREY MICHAEL G - Director

2020-05-22 M 10,530 d 0 62,290.00 direct

GREY MICHAEL G - Director

2020-05-22 S 10,530 $48.77 d 0 62,290.00 direct

CURTIS GEOFFREY M. - Officer EVP, CORPORATE AFFAIRS, CCO

2020-05-13 G 5,720 d 56,752 35,254.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments